June 17, 2014 — Navidea Biopharmaceuticals Inc. announced results from a post-hoc analysis of patient data from the ...
June 16, 2014 — Piramal Imaging released details from research presented at the 2014 annual meeting of the Society of ...
June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
June 10, 2014 — Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is ...
June 9, 2014 — The prominent role a single enzyme plays in cancer imaging has eluded researchers for years, but not ...
June 9, 2014 — ImaginAb Inc., in collaboration with Memorial Sloan-Kettering Cancer Center, will present at the 2014 ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
June 6, 2014 — Among the collection of aspiring medical isotope production companies looking to build facilities in the ...
May 12, 2014 — AC Immune SA and Piramal Imaging, a division of Piramal Enterprises Ltd., have entered into an exclusive ...
The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron ...
April 29, 2014 — GE Healthcare announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a ...
April 17, 2014 — ICB Intl. Inc., (ICBI), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in ...
April 16, 2014 — Navidea Biopharmaceuticals Inc. held an update meeting with the Committee for Medicinal Products for ...
April 4, 2014 — Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and ...
April 1, 2014 — A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise ...
April 1, 2014 — Scientists at the Riken Center for Life Science Technologies in Kobe, Japan, have used PET (positron ...
March 20, 2014 — The U.S. Food and Drug Administration (FDA) approved a third beta-amyloid plaque positron emission ...
March 18, 2014 — Brain imaging using nuclear imaging radiotracers can detect early evidence of Alzheimer's disease that ...
March 7, 2014 — Navidea Biopharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted ...
March 4, 2014 — Advanced Accelerator Applications (AAA), a growing international player in molecular nuclear medicine ...
February 28, 2014 — Navidea Biopharmaceuticals Inc. is a biopharmaceutical company focused on precision diagnostic ...
June 17, 2014 